Aligos Therapeutics Inc. (ALGS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aligos Therapeutics Inc.

    NASDAQ: ALGS · Real-Time Price · USD
    10.07
    -0.17 (-1.66%)
    At close: Oct 03, 2025, 3:59 PM
    10.07
    0.00%
    After-hours: Oct 03, 2025, 05:18 PM EDT

    Aligos Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 37M 135.7M 81.35M 186.82M
    Short-Term Investments
    		 19.94M n/a 44.48M 3.92M
    Long-Term Investments
    		 n/a n/a n/a 15.11M
    Other Long-Term Assets
    		 627K 625K -2.53M 866K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 5.2M 5.38M 7.72M 13.69M
    Total Current Assets
    		 62.14M 141.08M 133.54M 204.42M
    Property-Plant & Equipment
    		 7.33M 9.82M 12.51M 14.97M
    Goodwill & Intangibles
    		 n/a n/a n/a -3.77M
    Total Long-Term Assets
    		 7.95M 10.44M 13.15M 30.95M
    Total Assets
    		 70.09M 151.53M 146.69M 235.37M
    Account Payables
    		 2.57M 2.52M 4.74M 3.02M
    Deferred Revenue
    		 151K 1.22M 9.21M 7.64M
    Short-Term Debt
    		 3.46M 3.24M 3.14M 2.91M
    Other Current Liabilities
    		 12.99M 14.41M 11.42M 21.25M
    Total Current Liabilities
    		 21.74M 23.91M 33.13M 38.96M
    Long-Term Debt
    		 4.92M 7.9M n/a n/a
    Other Long-Term Liabilities
    		 77.33M 27.64M n/a 133K
    Total Long-Term Liabilities
    		 77.33M 35.54M 9.66M 11.68M
    Total Liabilities
    		 99.07M 59.45M 42.79M 50.64M
    Total Debt
    		 8.38M 11.14M 12.57M 14.46M
    Book Value
    		 -28.97M 92.08M 103.9M 184.73M
    Book Value Per Share
    		 -4.62 3.70 2.43 4.64
    Common Stock
    		 8K 7K 4K 4K
    Retained Earnings
    		 -618.01M -486.8M -399.12M -303.07M
    Comprehensive Income
    		 451K 545K 401K 452K
    Shareholders Equity
    		 -28.97M 92.08M 103.9M 184.73M
    Total Investments
    		 19.94M -70K 44.48M 19.03M

    Add to Watchlist